XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ (2,767,099) $ 1,368,152
Discontinued operations 0 994,217
Net income (loss) from continuing operations (2,767,099) 373,935
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities:    
Depreciation and amortization expense 3,272,085 2,455,576
Share-based compensation 132,148 354,914
Decrease in non-cash contingent consideration (68,334) (180,110)
Decrease (increase) in cash surrender value of life insurance policies over premiums paid 598,355 (226,897)
Gain on receivable of life insurance policy proceeds (611,330) 0
Increase in noncash interest expense 4,791 27,666
Gain on forgiveness of debt 0 (2,187,140)
Net changes in assets and liabilities affecting operating activities:    
Accounts receivable (5,527,690) 3,230,220
Inventories 2,949,443 2,309,914
Other current assets and other assets 1,227,030 866,987
Accounts payable and other current liabilities 4,658,782 (3,008,323)
Other long-term liabilities (1,688,143) (526,189)
Net cash provided by operating activities from continuing operations 2,180,038 3,490,553
Discontinued operations 0 994,217
Net cash provided by operating activities 2,180,038 4,484,770
Cash flows from investing activities:    
Additions to property and equipment (164,241) (34,531)
Note receivable investment funding 0 (200,000)
Cash paid for acquisitions (13,500,000) 0
Additions to intangible assets (50,248) (132,323)
Net cash used in investing activities (13,714,489) (366,854)
Cash flows from financing activities:    
Borrowings on line of credit 39,000,000 29,000,000
Repayments on line of credit (35,000,000) (30,000,000)
Cash payment of contingent consideration (501,505) (1,423,586)
Repurchase of common shares (788,295) (777,664)
Net cash provided by (used in) financing activities 2,710,200 (3,201,250)
Net increase (decrease) in cash and cash equivalents (8,824,251) 916,666
Cash and cash equivalents at beginning of period 27,040,816 24,753,796
Cash and cash equivalents at end of period $ 18,216,565 $ 25,670,462